Cargando…

1052. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant recipients

BACKGROUND: The prevalence of chronic hepatitis C virus (HCV) infection in patients with cancer in the U.S. has been reported to be 1.5% overall and up to 10.6% in specific subgroups. Testing for antibody to HCV (anti-HCV) is a low-cost diagnostic method in widespread use worldwide; however, the opt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Harrys A, Angelidakis, Georgios, Jiang, Ying, Economides, Minas, Yibirin, Marcel, MD, Robert Orlowski, Champlin, Richard, Verstovsek, Srdan, Raad, Issam I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777433/ http://dx.doi.org/10.1093/ofid/ofaa439.1238

Ejemplares similares

Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies
por: Torres, Harrys A., et al.
Publicado: (2022)

The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma
por: Economides, Minas, et al.
Publicado: (2017)

288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib
por: Malek, Alexandre, et al.
Publicado: (2019)

1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS
por: Senapati, J., et al.
Publicado: (2022)

810. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations
por: Gerges, Bahgat, et al.
Publicado: (2020)

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
por: Raad, Issam I, et al.
Publicado: (2018)

Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017)

Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Direct-acting Antivirals Induce Lymphoproliferative Disease Response in HCV-infected Patients: A Prospective Case Series
por: Hosry, Jeff, et al.
Publicado: (2017)

Cancer and COVID-19
por: Malek, Alexandre E, et al.
Publicado: (2020)

Invasive Mold Infections (IMIs) of the Central Nervous System (CNS) in Patients with Hematologic Cancer (HC) (2000–2016): Uncommon but Deadly
por: Economides, Minas Platon, et al.
Publicado: (2017)

272. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy vs. Solid Tumor
por: Wilson Dib, Rita, et al.
Publicado: (2019)

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021)

1228. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
por: Chaftari, Patrick, et al.
Publicado: (2020)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)

Concerti pour clavecin BWV 1044, 1052, 1054
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1994)

Salvage Therapy in Cancer Patients With Hepatitis C Infection Failing Direct-Acting Antivirals: A Prospective Study
por: Pritchard, Haley, et al.
Publicado: (2017)

Pasteurella multocida vertebral osteomyelitis, myositis and epidural abscess in a diabetic cirrhotic patient
por: Malek, Alexandre E., et al.
Publicado: (2019)

2123. Novel Antimicrobial Polycarbonate Coating for Intravenous Connectors
por: Truong, Y Lan, et al.
Publicado: (2023)

2124. Novel Polygalacturonic and Caprylic Acid (PG+CAP) Antimicrobial Wound Ointment Effectiveness in Eradicating C. auris Biofilms In Vitro
por: Truong, Y Lan, et al.
Publicado: (2023)

1052. Antimicrobial Stewardship: On Board with Lean Daily Management System
por: Monsees, Elizabeth, et al.
Publicado: (2019)

1164. In vitro Antimicrobial Efficacy of Novel Antimicrobial Dacron Vascular Grafts in the Inhibition of Multidrug-Resistant Gram-Negative Biofilm
por: Vargas-Cruz, Nylev, et al.
Publicado: (2019)

683. Assessment of Biofilm Eradication and Cytotoxicity of a Novel Polygalacturonic Acid + Caprylic Acid Wound Ointment Compared with Antiseptic Wound Ointments
por: Gerges, Bahgat, et al.
Publicado: (2019)

1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy
por: Malek, Alexandre, et al.
Publicado: (2021)

Insights on the Role of Antimicrobial Cuffed Endotracheal Tubes in Preventing Transtracheal Transmission of VAP Pathogens from an In Vitro Model of Microaspiration and Microbial Proliferation
por: Rosenblatt, Joel, et al.
Publicado: (2014)

Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients
por: Sheshadri, Ajay, et al.
Publicado: (2020)

416. Culture-Documented Invasive Mold Infections (cIMIs) at MD Anderson Cancer Center (MDACC) in Houston, Texas Pre- and Post-Hurricane Harvey
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2018)

919. Rates of False-Positive Hepatitis B Surface Antigen Is Low in Cancer Patients
por: Klingen, Joseph, et al.
Publicado: (2021)

1375. In vitro Activity of Cefiderocol and Comparator Agents against Gram-Negative Isolates from Cancer Patients
por: Rolston, Kenneth V I, et al.
Publicado: (2018)

357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19
por: Malek, Alexandre, et al.
Publicado: (2021)

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2022)

Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

Prevention of Cardiac Implantable Electronic Device–Related Infection in Patients With Cancer: The Role of a Comprehensive Prophylactic Bundle Approach That Includes the Antimicrobial Mesh
por: Khalil, Melissa, et al.
Publicado: (2020)

Activity of Cefiderocol and Comparators against Isolates from Cancer Patients
por: Rolston, Kenneth V. I., et al.
Publicado: (2020)

1171. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2vfns5qo0airiihadb2l9r8vqq